Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamibarotene in Relapsed/Refractory APL (STAR-1)
NCT00520208Phase 2Completed
- Sponsor
- LadRx
- Start
- Sep 2007
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tamibarotene in acute promyelocytic leukemia (APL), sponsored by LadRx. Started Sep 2007; status: completed.
02
Drugs
tamibarotene
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00520208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520208.